ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $465K of Zentalis Pharmaceuticals, Inc.
Sold$465,381
$46.54Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Fri, Nov 27 open, $46.89
- +5.4%
- S&P 500, same days
- +4.5%
Measured over 30 trading days, to the Jan 12 close.
Traded Mon, Nov 23. Filed Wed, Nov 25. Returns use the Nov 27 open and the Jan 12 close. Not investment advice.